Obesity-related Host Susceptibility Factors for Asthma in Women

女性哮喘与肥胖相关的宿主易感性因素

基本信息

  • 批准号:
    7928913
  • 负责人:
  • 金额:
    $ 17.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-15 至 2013-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The candidate is a clinically trained pulmonologist who has recently embarked on a career in translational research at the University of New Mexico. The candidate's long-term objective is to establish a fully funded, independent research career and provide national leadership in the field of asthma epidemiology. He is interested in investigating the role of obesity-related host susceptibility factors for asthma in women. Interest in this field developed during routine clinical observations that prompted the candidate to re-emphasize his past training in epidemiology during his fellowship. The proposed career development plan incorporates a multi-disciplinary program designed to provide an intense, closely mentored, patient-oriented research experience in association with a structured didactic curriculum in specific competencies related to the candidate's project and career goals. Under the mentorship of senior investigators, Marianne Benwick, Ph.D., Mark Schuyler, MD and Clifford Quails, Ph.D., the candidate will investigate whether central adiposity and the pro-inflammatory balance of serum adipokines affect specific physiologic and pathophysiologic sub- phenotypes of asthma in pre-menopausal women with asthma. Specific Aim 1 will examine the association between central adiposity and ainway outcome measures, using a cross-sectional study of 200 pre- menopausal women with methacholine challenge-confirmed asthma. Airway outcome measures include dynamic hyperinflation following methacholine bronchoprovocation and markers of eosinophilic inflammation and oxidant stress in induced sputum and exhaled breath condensate respectively. Specific Aim 2 involves a nested prospective cohort of 19 obese and 19 normal weight eumenorrheic women with asthma. The effect of diurnal and menstrual phase-related physiological variation in serum leptin to adiponectin ratio on ainn/ay outcome measures will be studied. This area of research is considered a high priority at the 2004 workshop on 'Obesity and Asthma' by the NHLBI. This study may help define the mechanistic basis forthe relationship between obesity and asthma, which in turn may make possible newer ways of treatment and prevention of asthma. RELEVANCE (See instructions): This study may help define the mechanistic basis for the relationship between asthma and obesity-related host susceptibility factors in women, which in turn may make possible newer ways of treatment and prevention of asthma. This study will also provide mentored training to a clinician for a patient-oriented research career. (End of Abstract)
描述(由申请人提供):候选人是一名临床训练有素的肺科医生,最近在新墨西哥大学开始了转化研究的职业生涯。候选人的长期目标是建立一个完全资助的独立研究生涯,并在哮喘流行病学领域发挥国家领导作用。他对研究肥胖相关宿主易感因素在女性哮喘中的作用感兴趣。对这一领域的兴趣是在日常临床观察中发展起来的,这促使候选人再次强调他在研究期间接受的流行病学培训。拟议的职业发展计划包括一个多学科项目,旨在提供密集的、密切指导的、以患者为导向的研究经验,并结合与候选人的项目和职业目标相关的特定能力的结构化教学课程。在资深研究员Marianne Benwick博士、Mark Schuyler博士和Clifford Quails博士的指导下,候选人将研究中枢性肥胖和血清脂肪因子的促炎平衡是否影响绝经前哮喘妇女哮喘的特定生理和病理生理亚表型。特异性目的1将通过对200例经甲胆碱挑战证实的哮喘绝经前妇女的横断面研究,检验中枢性肥胖与预后指标之间的关系。气道结局测量包括甲胆碱支气管激发后的动态恶性膨胀,以及诱导痰和呼出冷凝水中嗜酸性粒细胞炎症和氧化应激标志物。特异性目标2涉及一个嵌套的前瞻性队列,包括19名肥胖和19名体重正常的哮喘女性痛经。将研究昼夜和经期相关的血清瘦素/脂联素比值生理变化对ainn/ay结局指标的影响。在2004年NHLBI举办的“肥胖与哮喘”研讨会上,这一研究领域被认为是一个高度优先事项。这项研究可能有助于确定肥胖和哮喘之间关系的机制基础,进而可能为治疗和预防哮喘提供新的方法。相关性(见说明):本研究可能有助于确定女性哮喘与肥胖相关宿主易感因素之间关系的机制基础,进而可能为治疗和预防哮喘提供新的方法。本研究亦将为临床医师提供指导训练,以发展以病人为导向的研究事业。(摘要结束)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AKSHAY SOOD其他文献

AKSHAY SOOD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AKSHAY SOOD', 18)}}的其他基金

Keeping rural minority 'essential' workplaces open safely during the COVID-19 pandemic: The role of frequent point-of-care molecular workplace surveillance for miners
在 COVID-19 大流行期间保持农村少数民族“基本”工作场所安全开放:对矿工进行频繁的护理点分子工作场所监测的作用
  • 批准号:
    10528559
  • 财政年份:
    2022
  • 资助金额:
    $ 17.93万
  • 项目类别:
Keeping rural minority 'essential' workplaces open safely during the COVID-19 pandemic: The role of frequent point-of-care molecular workplace surveillance for miners
在 COVID-19 大流行期间保持农村少数民族“基本”工作场所安全开放:对矿工进行频繁的护理点分子工作场所监测的作用
  • 批准号:
    10253980
  • 财政年份:
    2020
  • 资助金额:
    $ 17.93万
  • 项目类别:
Effectiveness of Innovative Research Mentor Interventions among Underrepresented Minority Faculty in the Southwest
西南地区代表性不足的少数族裔教师创新研究导师干预的有效性
  • 批准号:
    10686872
  • 财政年份:
    2019
  • 资助金额:
    $ 17.93万
  • 项目类别:
Effectiveness of Innovative Research Mentor Interventions among Underrepresented Minority Faculty in the Southwest
西南地区代表性不足的少数族裔教师创新研究导师干预的有效性
  • 批准号:
    10198950
  • 财政年份:
    2019
  • 资助金额:
    $ 17.93万
  • 项目类别:
Effectiveness of Innovative Research Mentor Interventions among Underrepresented Minority Faculty in the Southwest
西南地区代表性不足的少数族裔教师创新研究导师干预的有效性
  • 批准号:
    10459273
  • 财政年份:
    2019
  • 资助金额:
    $ 17.93万
  • 项目类别:
Effectiveness of Innovative Research Mentor Interventions among Underrepresented Minority Faculty in the Southwest
西南地区代表性不足的少数族裔教师创新研究导师干预的有效性
  • 批准号:
    9975185
  • 财政年份:
    2019
  • 资助金额:
    $ 17.93万
  • 项目类别:
Household Air Pollution from Solid Fuel Combustion Smoke and Global Health Equali
固体燃料燃烧烟雾造成的家庭空气污染与全球健康平等
  • 批准号:
    8785206
  • 财政年份:
    2014
  • 资助金额:
    $ 17.93万
  • 项目类别:
Novel role for adiponectin-enhancing drugs for asthma in the obese
脂联素增强药物治疗肥胖哮喘的新作用
  • 批准号:
    8726688
  • 财政年份:
    2014
  • 资助金额:
    $ 17.93万
  • 项目类别:
Obesity-related Host Susceptibility Factors for Asthma in Women
女性哮喘与肥胖相关的宿主易感性因素
  • 批准号:
    8308431
  • 财政年份:
    2009
  • 资助金额:
    $ 17.93万
  • 项目类别:
Obesity-related Host Susceptibility Factors for Asthma in Women
女性哮喘与肥胖相关的宿主易感性因素
  • 批准号:
    7739002
  • 财政年份:
    2009
  • 资助金额:
    $ 17.93万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 17.93万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 17.93万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 17.93万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 17.93万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 17.93万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 17.93万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 17.93万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 17.93万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 17.93万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 17.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了